FHL2 expression and variants in hypertrophic cardiomyopathy

Based on evidence that FHL2 (four and a half LIM domains protein 2) negatively regulates cardiac hypertrophy we tested whether FHL2 altered expression or variants could be associated with hypertrophic cardiomyopathy (HCM). HCM is a myocardial disease characterized by left ventricular hypertrophy, di...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, Felix W., Reischmann, Silke, Schwalm, Aileen, Unger, Andreas, Ramanujam, Deepak, Münch, Julia, Müller, Oliver J., Hengstenberg, Christian, Galve, Enrique, Charron, Philippe, Linke, Wolfgang A., Engelhardt, Stefan, Patten, Monica, Richard, Pascale, van der Velden, Jolanda, Eschenhagen, Thomas, Isnard, Richard, Carrier, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215105/
https://www.ncbi.nlm.nih.gov/pubmed/25358972
http://dx.doi.org/10.1007/s00395-014-0451-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215105/
https://www.ncbi.nlm.nih.gov/pubmed/25358972
http://dx.doi.org/10.1007/s00395-014-0451-8

Ejemplares similares